A plasma-derived von Willebrand factor/factor VIII concentrate (Wilate).
D002986:Clinical Trials as Topic; D017277:Drug Approval; D004338:Drug Combinations; D005169:Factor VIII / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D010949:Plasma; D014481:United States; D014486:United States Food and Drug Administration; D014842:von Willebrand Diseases / Q000628:therapy*; D014841:von Willebrand Factor / Q000008:administration & dosage / Q000627:therapeutic use*
D004338:Drug Combinations; D014841:von Willebrand Factor; D005169:Factor VIII